Profit

Indian Pharma to prune R&D budget

PUBLISHED ON: November 5, 2008 | Duration: 1 min, 51 sec

   
loading..
The deepening global financial crisis is forcing a bitter pill down the throat of Indian drug makers with companies pruning their ambitious R&D plans. "If an industry's viewpoint is taken some changes will be there. The R&D spending will go down to 6-8 per cent from 10 per cent," said Dr CB Rao, deputy MD, Orchid Chemicals.
ALSO WATCH
Centre's Ambitious Health Cover Gets Rs. 2,000 Crore: Key Things To Know

................................ Advertisement ................................

................................ Advertisement ................................